These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9146046)

  • 21. Uncommon phenotypes of acute myelogenous leukemia: basophilic, mast cell, eosinophilic, and myeloid dendritic cell subtypes: a review.
    Lichtman MA; Segel GB
    Blood Cells Mol Dis; 2005; 35(3):370-83. PubMed ID: 16203163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype.
    Colado E; Alvarez-Fernández S; Maiso P; Martín-Sánchez J; Vidriales MB; Garayoa M; Ocio EM; Montero JC; Pandiella A; San Miguel JF
    Haematologica; 2008 Jan; 93(1):57-66. PubMed ID: 18166786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of p300 gene promoter methylation in acute leukemia.
    Chim CS; Wong AS; Kwong YL
    Cancer Genet Cytogenet; 2004 Apr; 150(2):164-7. PubMed ID: 15066326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of thrombopoietin and its receptor C-mpl in acute leukemia].
    Guo Y; Bian S; Luo M
    Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):120-3. PubMed ID: 11601235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute myeloid leukemia stem cells.
    Dick JE
    Ann N Y Acad Sci; 2005 Jun; 1044():1-5. PubMed ID: 15958691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vesnarinone exhibits antitumor effect against myeloid leukemia cells via apoptosis.
    Fujiwara H; Arima N; Otsubo H; Matsushita K; Hidaka S; Arimura K; Kukita T; Yamaguchi K; Tanaka H
    Exp Hematol; 1997 Oct; 25(11):1180-6. PubMed ID: 9328455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Podocalyxin is expressed in normal and leukemic monocytes.
    Riccioni R; Calzolari A; Biffoni M; Senese M; Riti V; Petrucci E; Pasquini L; Cedrone M; Lo-Coco F; Diverio D; Foà R; Peschle C; Testa U
    Blood Cells Mol Dis; 2006; 37(3):218-25. PubMed ID: 17059890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
    Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
    Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient lentiviral transduction of primary human acute myelogenous and lymphoblastic leukemia cells.
    Biagi E; Bambacioni F; Gaipa G; Casati C; Golay J; Biondi A; Introna M
    Haematologica; 2001 Jan; 86(1):13-6. PubMed ID: 11146564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukemic relapse as T-acute lymphoblastic leukemia in a patient with acute myeloid leukemia and a minor T-cell clone at diagnosis.
    Bellido M; Martino R; Aventín A; Carnicer MJ; Rubiol E; López O; Sierra J; Nomdedéu JF
    Haematologica; 2000 Oct; 85(10):1083-6. PubMed ID: 11025601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gene expression analysis of acute myeloid leukemia to understand leukemogenic pathways associated with differentiation inhibition].
    Ichikawa H
    Tanpakushitsu Kakusan Koso; 2005 Dec; 50(16 Suppl):2128-33. PubMed ID: 16411441
    [No Abstract]   [Full Text] [Related]  

  • 32. Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias.
    Caceres-Cortes JR; Alvarado-Moreno JA; Waga K; Rangel-Corona R; Monroy-Garcia A; Rocha-Zavaleta L; Urdiales-Ramos J; Weiss-Steider B; Haman A; Hugo P; Brousseau R; Hoang T
    Cancer Res; 2001 Aug; 61(16):6281-9. PubMed ID: 11507083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Leukemic retinal infiltrate in acute myeloid leukemia in remission].
    Görg C; Görg K; Gropp C; Havemann K
    Dtsch Med Wochenschr; 1984 Mar; 109(9):357-8. PubMed ID: 6583055
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cytokinetic studies in a paraleukoblastic leukemia].
    Kleiser G; Frey-Wettstein M
    Schweiz Med Wochenschr; 1967 Nov; 97(44):1473-4. PubMed ID: 5243261
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pathogenesis of acute leucopenic and leukemic myeloleucosis].
    Logoĭda DM
    Vrach Delo; 1967 Oct; 10():17-9. PubMed ID: 5258095
    [No Abstract]   [Full Text] [Related]  

  • 36. Preleukemia and leukemia.
    Dreyfus B
    Blood Cells; 1981; 7(3):591-2. PubMed ID: 6950796
    [No Abstract]   [Full Text] [Related]  

  • 37. [Growth mechanism of leukemic cells in acute myeloid leukemia].
    Nara N
    Rinsho Ketsueki; 1997 Apr; 38(4):257-61. PubMed ID: 9146046
    [No Abstract]   [Full Text] [Related]  

  • 38. [Proliferation and differentiation of leukemic cells in acute myelocytic leukemia].
    Nara N
    Rinsho Byori; 1998 May; 46(5):424-9. PubMed ID: 9627492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].
    Müller-Tidow C; Steur C; Mizuki M; Schwäble J; Brandts C; Berdel WE; Serve H
    Dtsch Med Wochenschr; 2002 Oct; 127(42):2195-200. PubMed ID: 12397548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Overexpression of differentiation inhibitory factor/nm23 in acute myeloid leukemia].
    Kado J; Yokoyama A
    Rinsho Ketsueki; 1998 Feb; 39(2):92-4. PubMed ID: 9545807
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.